Clear Investment Research »

Crispr Therapeutics shares owned by Clear Investment Research

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Clear Investment Research from 13F filings

Historical chart of Clear Investment Research investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Clear Investment Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Clear Investment Research

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3k 21 62.62

More positions owned by Clear Investment Research

Ishares Tr Core S&p500 Etf (IVV)
Graphic Packaging Holding Company (GPK)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Real Estate Etf (VNQ)
Vaneck Vectors Etf Tr Fallen Angel Hg (ANGL)
Ishares Tr Cores Msci Eafe (IEFA)
Apple (AAPL)
Scwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Scp Etf (IJR)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Scwab Strategic Tr Sht Tm Us Tres (SCHO)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Clear Investment Research

Top funds holding Crispr Therapeutics

ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics